Ebrahim, A.S.; Hailat, Z.; Bandyopadhyay, S.; Neill, D.; Kandouz, M.
The Value of EphB2 Receptor and Cognate Ephrin Ligands in Prognostic and Predictive Assessments of Human Breast Cancer. Int. J. Mol. Sci. 2021, 22, 8098.
https://doi.org/10.3390/ijms22158098
AMA Style
Ebrahim AS, Hailat Z, Bandyopadhyay S, Neill D, Kandouz M.
The Value of EphB2 Receptor and Cognate Ephrin Ligands in Prognostic and Predictive Assessments of Human Breast Cancer. International Journal of Molecular Sciences. 2021; 22(15):8098.
https://doi.org/10.3390/ijms22158098
Chicago/Turabian Style
Ebrahim, Abdul Shukkur, Zeyad Hailat, Sudeshna Bandyopadhyay, Daniel Neill, and Mustapha Kandouz.
2021. "The Value of EphB2 Receptor and Cognate Ephrin Ligands in Prognostic and Predictive Assessments of Human Breast Cancer" International Journal of Molecular Sciences 22, no. 15: 8098.
https://doi.org/10.3390/ijms22158098
APA Style
Ebrahim, A. S., Hailat, Z., Bandyopadhyay, S., Neill, D., & Kandouz, M.
(2021). The Value of EphB2 Receptor and Cognate Ephrin Ligands in Prognostic and Predictive Assessments of Human Breast Cancer. International Journal of Molecular Sciences, 22(15), 8098.
https://doi.org/10.3390/ijms22158098